Retinopathy of Prematurity (ROP) is a serious eye condition that affects premature infants. It occurs when the blood vessels in the retina (the light-sensitive layer at the back of the eye) develop abnormally. ROP can lead to vision problems and, in severe cases, blindness if not treated promptly.
Stage 1:Mildly abnormal blood vessel growth. Many infants with Stage 1 ROP improve without treatment.
Stage 2:Moderately abnormal blood vessel growth. Close monitoring is necessary as it can progress.
Stage 3:Severely abnormal blood vessel growth. Treatment may be required to prevent retinal detachment.
Stage 4:Partial retinal detachment. This stage often requires surgical intervention.
Stage 5:Complete retinal detachment, leading to significant vision loss or blindness.
Eye check-ups are critical for premature and low birth weight babies due to the increased risk of Retinopathy of Prematurity (ROP), a condition that can lead to vision impairment or blindness. Babies born prematurely (before 31 weeks of gestation) or with a birth weight of less than 1,500 grams are at higher risk for developing ROP, as their retina may not be fully developed at birth.
Regular eye screening and timely intervention are essential to detect early stages of ROP. If left undiagnosed or untreated, ROP can progress rapidly and cause irreversible damage to the retina. Early detection significantly increases the chances of preventing blindness in premature infants. Eye screenings are typically done between 4-6 weeks after birth, depending on the baby's gestational age and weight. Monitoring ROP development helps doctors make informed decisions about necessary treatments to save the baby's vision.
Anti-VEGF Injections: Anti-VEGF drugs, such as Ranibizumab (Lucentis) or Bevacizumab (Avastin), are injected into the eye to block the growth of abnormal blood vessels that contribute to ROP. These injections significantly reduce the risk of vision loss by preventing the progression of the disease and stabilizing the retina. Anti-VEGF injections are generally safe and highly effective in treating ROP, especially in its early stages.
Laser Treatment: Laser therapy is another common treatment for severe ROP. It involves using a laser to target and destroy abnormal blood vessels in the retina, preventing further damage. Laser treatment helps to stop the progression of ROP and preserve vision in many babies. It is especially useful when ROP has advanced, and Anti-VEGF injections are insufficient. Laser treatment is a proven method to manage ROP in premature infants.
At Kiran Eye Foundation, we offer specialized care for infants at risk of Retinopathy of Prematurity. Our team of expert ophthalmologists conducts thorough eye screenings for premature infants, starting shortly after birth. Early detection is crucial in managing ROP effectively and preventing serious complications.
Our compassionate team is dedicated to supporting both the child and their family throughout the treatment process, providing the highest standard of care in a nurturing environment.